(Total Views: 415)
Posted On: 05/14/2025 2:30:22 PM
Post# of 155271
Quote:
Is the data you prefer re: 66% available via research?
15 patients had a rise in PD-L1, 5 survived very long term, 10 (66.6% of the total) didn't.
Quote:
Nonetheless, I see only upside in the data as presented. Ambiguity? Yes, but no downside or hidden or damaging LL data weakness. Am I wrong to see only upside in the data?
Whether a PD-L1 inhibitor is warranted or not it's only upside if you can further elucidate the mechanism of action.
(8)
(0)
